---
schema_version: "secwatch.filing_event.v1"
accession: "0001490978-25-000099"
form_type: "8-K"
ticker: "SDGR"
cik: "0001490978"
company_name: "Schrodinger, Inc."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T19:11:47.466273+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Schrödinger Q2 revenue $54.8M (+16% YoY); narrows net loss; maintains revenue guidance, lowers expense guidance

## Summary
- Total revenue $54.8M (+16% YoY); software revenue $40.5M (+15%); drug discovery $14.2M (+19%).
- Net loss improved to $43.2M from $54.0M; non-GAAP net loss $47.5M.
- Guidance: Software revenue growth 10-15% reaffirmed; op. expenses expected lower than 2024; cash burn significantly lower.
- SGR-1505 FDA Fast Track; initial Phase 1 data presented; exploring strategic options; SGR-2921/SGR-3515 data Q4 2025.
- May 7% workforce reduction expected to save ~$30M annually; new CFO Richie Jain appointed.

## SEC filing metadata
- accession: 0001490978-25-000099
- form_type: 8-K
- ticker: SDGR
- cik: 0001490978
- company_name: Schrodinger, Inc.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1490978/000149097825000099/0001490978-25-000099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1490978/000149097825000099/sdgr-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001490978-25-000099
- JSON: https://secwatch.observer/filing/0001490978-25-000099.json
- Plain text: https://secwatch.observer/filing/0001490978-25-000099.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.